Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tango Therapeutics (TNGX) Non-Current Assets: 2020-2024

Historic Non-Current Assets for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to $50.1 million.

  • Tango Therapeutics' Non-Current Assets fell 10.16% to $46.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.4 million, marking a year-over-year decrease of 10.16%. This contributed to the annual value of $50.1 million for FY2024, which is 10.49% down from last year.
  • Tango Therapeutics' Non-Current Assets amounted to $50.1 million in FY2024, which was down 10.49% from $56.0 million recorded in FY2023.
  • In the past 5 years, Tango Therapeutics' Non-Current Assets registered a high of $61.2 million during FY2022, and its lowest value of $7.8 million during FY2021.
  • For the 3-year period, Tango Therapeutics' Non-Current Assets averaged around $55.8 million, with its median value being $56.0 million (2023).
  • Its Non-Current Assets has fluctuated over the past 5 years, first tumbled by 42.61% in 2021, then skyrocketed by 682.88% in 2022.
  • Over the past 5 years, Tango Therapeutics' Non-Current Assets (Yearly) stood at $13.6 million in 2020, then crashed by 42.61% to $7.8 million in 2021, then soared by 682.88% to $61.2 million in 2022, then dropped by 8.45% to $56.0 million in 2023, then fell by 10.49% to $50.1 million in 2024.